Italy and Belgium have joined France in moving to ban the use of the controversial hydroxychloroquine to treat Covid-19 patients as questions continue to mount over its safety.
On Wednesday, France revoked its decree authorizing the prescription of the anti-malarial drug for the novel coronavirus following a decision from the government’s health advisory agency.
Now Belgium’s health body has warned against using the drug outside of ongoing registered clinical trials.
Italy’s health authorities also concluded that there is too little evidence to support the use of hydroxychloroquine for Covid-19 and that the lack of proof means it should be banned outside of clinical trials.
